Rapport Therapeutics, Inc. Common StockShare Price
|
|
Share Price & Volume
| Previous Close | $37.07 | |
| Open | +0.76% | $37.35 |
| Day Low | -6.66% | $34.60 |
| Day High | +2.59% | $38.03 |
| 52-Week Low | -79.15% | $7.73 |
| 52-Week High | +14.02% | $42.27 |
| Day Volume | 275,473 | |
| Average Volume | 343,891 | |
| EPS (TTM) | -$2.60 | |
| P/E (TTM) | -13.53x | |
| FWD P/E (NTM) | - | |
| Next Earnings Date | Aug 6, 2026 |
| Market Cap | 1,283,986,201 | |
| Shares Outstanding (Millions) | 36,497,618 | |
| Dividend | - | |
| Beta | - | |
| ROE | -0.28% | |
| ROA | -0.19% |
Analyst Ratings and Price Targets
Current:
$35.18
Average:
$50.67
(+44.02%)
Low:
$46.00
(+30.76%)
High:
$53.00
(+50.65%)
You need to login to see this data
| BTIG | Reiterates | Buy | $53.00 | +50.65% | May 7, 2026 |
| BTIG | Maintains | Buy | $53.00 | +50.65% | Mar 10, 2026 |
| Wells Fargo | Maintains | Overweight | $46.00 | +30.76% | Mar 10, 2026 |
Headquarters
Boston, DE, USA
Sector
Industry
# of Employees
69